Structure Therapeutics (GPCR) Assets Average (2023 - 2026)
Structure Therapeutics (GPCR) posted quarterly Assets Average of $1.5 billion for Q1 2026, up 74.7% year-over-year from $884.9 million in Q1 2025, and up 27.98% quarter-over-quarter from $1.2 billion in Q4 2025.
Structure Therapeutics (GPCR) Assets Average (2023 - 2026) Analysis & Trends
Structure Therapeutics' Assets Average history runs 4 years deep, the most recent figure standing at $1.5 billion for Q1 2026.
- In Q1 2026, Assets Average rose 74.7% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 74.7% YoY), while the FY2025 annual figure was $1.2 billion, up 79.54% from the prior year.
- Assets Average for Q1 2026 stood at $1.5 billion, up from $1.2 billion in the prior quarter.
- The five-year high for Assets Average was $1.5 billion in Q1 2026, with the low at $172.6 million in Q1 2023.
- The 4-year median for Assets Average is $824.3 million (2025), against an average of $716.8 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average surged 321.77% in 2024, then dropped 12.32% in 2025.
- Structure Therapeutics' Assets Average stood at $349.2 million in 2023, then surged by 162.97% to $918.3 million in 2024, then soared by 31.56% to $1.2 billion in 2025, then advanced by 27.98% to $1.5 billion in 2026.
- Business Quant data shows GPCR's Assets Average at $1.5 billion in Q1 2026, $1.2 billion in Q4 2025, and $824.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Structure Therapeutics | 11.65 Bn | 11.65 Bn | - | 1.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Bn |
| Mar 31, 2026 | 1.55 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 30, 2025 | 824.30 Mn |
| Jun 30, 2025 | 841.50 Mn |
| Mar 31, 2025 | 884.94 Mn |
| Dec 31, 2024 | 918.27 Mn |
| Sep 30, 2024 | 940.12 Mn |
| Jun 30, 2024 | 702.13 Mn |
| Mar 31, 2024 | 469.62 Mn |
| Dec 31, 2023 | 349.19 Mn |
| Sep 30, 2023 | 222.90 Mn |
| Jun 30, 2023 | 238.39 Mn |
| Mar 31, 2023 | 172.60 Mn |